The markers GPX3, PDGFRL, RGS2, and SERPINE1 were found to be significantly increased in the high-risk group, suggesting that all of these markers may be implicated in the malignancy processes for STAD patients and may be cancer-promoting factors. This evidence concerns the gene SERPINE1 and gastric adenocarcinoma.